Wang C, Yu KX, Chen Y. Metastatic clear cell sarcoma of the pancreas: From diagnosis to treatment. World J Clin Cases 2024; 12(17): 2925-2927 [PMID: 38898874 DOI: 10.12998/wjcc.v12.i17.2925]
Corresponding Author of This Article
Yu Chen, Doctor, Associate Chief Physician, Department of Orthopedics, Chongqing Hospital of Traditional Chinese Medicine, No. 6 Panxi Seventh Branch Road, Jiangbei District, Chongqing 400021, China. 359410356@qq.com
Research Domain of This Article
Oncology
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Jun 16, 2024; 12(17): 2925-2927 Published online Jun 16, 2024. doi: 10.12998/wjcc.v12.i17.2925
Metastatic clear cell sarcoma of the pancreas: From diagnosis to treatment
Chen Wang, Ke-Xiao Yu, Yu Chen
Chen Wang, Ke-Xiao Yu, Yu Chen, Department of Orthopedics, Chongqing Hospital of Traditional Chinese Medicine, Chongqing 400021, China
Author contributions: Wang C, Yu KX and Chen Y discussed and designed the manuscript; Wang C wrote and edited the manuscript; Chen Y designed the overall concept and outline of the manuscript; all authors have read and approved the final manuscript.
Conflict-of-interest statement: We have no financial relationships to disclose.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Yu Chen, Doctor, Associate Chief Physician, Department of Orthopedics, Chongqing Hospital of Traditional Chinese Medicine, No. 6 Panxi Seventh Branch Road, Jiangbei District, Chongqing 400021, China. 359410356@qq.com
Received: February 27, 2024 Revised: April 21, 2024 Accepted: April 24, 2024 Published online: June 16, 2024 Processing time: 98 Days and 2.2 Hours
Abstract
This article presents a comprehensive case report on an uncommon instance of metastatic clear cell sarcoma (CCS) originating from the pancreas. The high mortality rate of pancreatic carcinoma underscores the importance of precise diagnosis and early detection. The authors report a novel case of CCS with pancreatic metastasis, detailing successful surgical intervention through distal pancreatectomy and splenectomy, resulting in favourable outcomes. This study highlights the standard role of surgery in treating advanced CCS and emphasizes preoperative imaging and thorough patient history assessment. This article also underscores the necessity for long-term surveillance due to the potential for recurrence or metastasis. Despite the favourable recovery postsurgery, the absence of subsequent follow-up evaluation prompts consideration of the need for extended monitoring. This article raises questions about the nature of the pancreatic lesion and suggests the possibility of a primary lesion. Further evidence is crucial to establish the correlation between the features related to the development of the patient's primary and metastatic tumours. In conclusion, this study offers valuable insights into metastatic CCS of the pancreas, highlighting the importance of regular postoperative follow-up for improved outcomes through early detection and intervention.
Core Tip: This article presents a unique case of metastatic clear cell sarcoma (CCS) originating from the pancreas, emphasizing the rarity of secondary clear cell carcinomas in this organ. Successful surgical intervention, including distal pancreatectomy and splenectomy, resulted in favorable outcomes. The study underscores the standard role of surgery in treating advanced CCS, highlights the importance of preoperative imaging, and advocates for thorough long-term surveillance due to the potential for recurrence. The article raises questions about the nature of the pancreatic lesion, suggesting the need for additional evidence to establish its primary or metastatic origin.
